RT Journal Article
SR Electronic
T1 Factors associated with the clinical outcome of patients with relapsed/refractory CD19<sup>+</sup> acute lymphoblastic leukemia treated with ARI-0001 CART19-cell therapy
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e003644
DO 10.1136/jitc-2021-003644
VO 9
IS 12
A1 Ortiz-Maldonado, Valentín
A1 Rives, Susana
A1 Español-Rego, Marta
A1 Alonso-Saladrigues, Anna
A1 Montoro, Mercedes
A1 Magnano, Laura
A1 Giné, Eva
A1 Pascal, Mariona
A1 Díaz-Beyá, Marina
A1 Castella, Maria
A1 Català, Albert
A1 Faura, Anna
A1 Rodríguez-Lobato, Luis Gerardo
A1 Oliver-Caldes, Aina
A1 Martínez-Roca, Alexandra
A1 Rovira, Montserrat
A1 González-Navarro, E Azucena
A1 Ortega, Juan Ramón
A1 Cid, Joan
A1 Lozano, Miquel
A1 Garcia-Rey, Enric
A1 Fernández, Sara
A1 Castro, Pedro
A1 Jordan, Iolanda
A1 Villamor, Neus
A1 Aymerich, Marta
A1 Torrebadell, Montserrat
A1 Deyà, Àngela
A1 Fernández de Larrea, Carlos
A1 Benitez-Ribas, Daniel
A1 Trias, Esteve
A1 Varea, Sara
A1 Calvo, Gonzalo
A1 Esteve, Jordi
A1 Urbano-Ispizua, Alvaro
A1 Juan, Manel
A1 Delgado, Julio
YR 2021
UL http://jitc.bmj.com/content/9/12/e003644.abstract